Anika Therapeutics, Inc. Income Statement

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 40.14M55.56M64.78M71.36M75.08M105.59M93.00M103.38M113.42M105.56M114.61M130.46M147.79M113.83M120.79M119.91M
Cost of Revenue 13.67M23.83M26.78M28.99M22.77M20.93M21.05M24.03M27.36M31.28M28.75M61.43M64.85M40.61M38.26M43.91M
Gross Profit 26.47M31.73M37.99M42.37M52.32M84.67M71.95M79.35M86.06M74.28M85.86M69.03M82.94M73.22M82.53M76.00M
Operating items
Research & Development 8.18M6.87M6.17M5.39M7.06M8.14M8.99M10.73M18.79M18.19M16.66M23.43M27.33M18.32M21.76M25.54M
Selling, General & Administrative 10.55M17.32M17.86M14.73M12.94M15.07M14.82M18.01M21.54M34.34M34.95M60.06M74.10M51.23M59.92M55.55M
Restructuring Costs 2.15M2.54M
Other Operating Expenses 13.67M23.83M26.78M28.99M22.48M20.93M21.05M24.03M27.36M7.14M-22.98M-21.09M
Operating Expenses 34.55M48.02M50.81M51.64M42.47M44.15M44.87M52.77M67.69M52.53M51.62M97.35M80.33M69.55M81.69M81.10M
Operating Income 5.59M7.54M13.97M19.72M32.61M61.45M48.13M50.61M45.73M21.75M34.25M-28.32M2.62M3.67M0.84M-5.10M
EBIT 5.59M7.54M13.97M19.72M32.61M61.45M48.13M50.61M45.73M21.75M34.25M-28.32M2.62M3.67M0.84M-5.10M
Non-operating items
Interest & Investment Income -0.07M-0.19M-0.18M-0.19M-0.13M0.06M0.12M0.26M0.47M1.46M1.87M-0.30M-0.19M0.65M2.31M2.34M
Net income details
EBT 5.51M11.94M15.96M26.17M33.06M63.23M48.61M50.87M48.45M26.23M38.30M-28.62M4.96M4.32M3.16M-4.08M
Tax Provisions 1.82M3.03M5.32M8.29M11.90M23.19M18.46M18.55M15.38M6.83M8.93M-4.64M-1.71M4.21M6.59M6.06M
Profit After Tax 3.69M4.32M8.47M11.76M20.57M38.32M30.76M32.55M31.82M18.72M27.19M-23.98M4.13M-14.86M-82.67M-56.38M
Income from Continuing Operations 3.69M8.92M10.64M17.88M21.16M40.05M30.15M32.32M33.07M19.39M29.37M-23.98M6.66M0.12M-3.44M-10.14M
Consolidated Net Income 3.69M8.92M10.64M17.88M21.16M40.05M30.15M32.32M33.07M19.39M29.37M-23.98M6.66M-17.06M-79.23M-47.56M
Income towards Parent Company 3.69M8.92M10.64M17.88M21.16M40.05M30.15M32.32M33.07M19.39M29.37M-23.98M6.66M-17.06M-79.23M-47.56M
Net Income towards Common Stockholders 3.69M8.92M10.64M17.88M21.16M40.05M30.15M32.32M33.07M19.39M29.37M-23.98M6.66M-17.06M-79.23M-47.56M
Additional items
EPS (Basic) 0.320.340.650.891.462.612.062.222.181.301.93-1.690.29-1.02-5.64-3.83
EPS (Weighted Average and Diluted) 0.320.320.620.821.392.512.012.152.111.271.89-1.690.28-1.02-5.64-3.83
Shares Outstanding (Weighted Average) 11.44M13.48M13.62M13.81M13.83M14.50M14.64M14.62M14.66M14.21M14.27M14.21M14.44M14.61M14.64M14.65M
Shares Outstanding (Diluted Average) 11.56M13.65M13.75M14.83M15.28M15.35M
EBITDA 3.69M1.77M7.95M12.17M21.53M35.52M28.60M31.88M34.35M17.98M26.82M-22.63M2.96M-15.58M-82.17M-57.23M
Tax Rate 33.10%25.34%33.32%31.68%36.01%36.67%37.97%36.46%31.74%26.05%23.31%16.22%97.25%